SCHEMBL2292809

SCHEMBL2292809

CC(=O)OC1CCCCC1O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.50
CHRM2 P08172 5/20 0.43
CHRM1 P11229 3/20 0.43
CHRM4 P08173 2/20 0.43
CHRM3 P20309 2/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
CYP2D6 P10635 2/20 0.42
SLC18A3 Q16572 2/20 0.41
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
NPY4R P50391 1/20 0.37
NPY5R Q15761 1/20 0.37
ALDH1A1 P00352 1/20 0.33
METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2293227 1.00 GSR (0.50) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL2293222 1.00 GSR (0.50) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL16250349 0.98 GSR (0.52) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL4915341 0.98 GSR (0.52) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL9325357 0.95 CHRM2 (0.47) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL9325366 0.95 CHRM2 (0.47) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL789422 0.95 CHRM2 (0.47) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL7926056 0.85 CHRM2 (0.48) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL7920287 0.85 CHRM2 (0.48) GSRCHRM2CHRM1CHRM4CHRM3
SCHEMBL7926060 0.85 CHRM2 (0.48) GSRCHRM2CHRM1CHRM4CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3275649-A None JP disclosed
CN-107108561-B Heteroaryl compounds as IRAK inhibitors and uses thereof 默克专利有限公司 2020-08-28 CN disclosed
CN-106054302-A Polaroid protection film, polaroid therewith, and manufacturing method for polaroid protection film 柯尼卡美能达株式会社 2016-10-26 CN disclosed
US-8211519-B2 Composition for forming gas-barrier material, gas-barrier material, a method of producing the same, and gas-barrier packing material TOYO SEIKAN KAISHA, LTD. (JP) 2012-07-03 US disclosed
US-8115029-B2 Oxidizing a substrate using a catalyst of a complex of cobalt and N-hydroxysuccinimide, N-hydroxyphthalimide, or N-hydroxymaleimide; alkanes, alkenes, cycloalkanes, cycloalkenes, aromatics, aryl aldehydes, aryl carboxylic acids, benzyl alcohols UNIVERSITY OF KANSAS (US) 2012-02-14 US disclosed
US-8115029-B2 Oxidizing a substrate using a catalyst of a complex of cobalt and N-hydroxysuccinimide, N-hydroxyphthalimide, or N-hydroxymaleimide; alkanes, alkenes, cycloalkanes, cycloalkenes, aromatics, aryl aldehydes, aryl carboxylic acids, benzyl alcohols UNIVERSITY OF KANSAS (US) 2012-02-14 US disclosed
US-20110200836-A1 GAS-BARRIER MATERIAL HAVING EXCELLENT ANTI-BLOCKING PROPERTY AND METHOD OF PRODUCING THE SAME TOYO SEIKAN KAISHA, LTD. (JP) 2011-08-18 US disclosed
US-7989602-B2 having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity; asthma, allergic rhinitis, dermatitis, psoriasis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, multiple sclerosis, diabetes, systemic lupus THE MALAGHAN INSTITUTE OF MEDICAL RESEARCH (NZ) 2011-08-02 US disclosed
EP-2170966-B1 CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER BAUSCH & LOMB (US) 2011-03-23 EP disclosed
US-20100015449-A1 COMPOSITION FOR FORMING GAS-BARRIER MATERIAL, GAS-BARRIER MATERIAL, A METHOD OF PRODUCING THE SAME, AND GAS-BARRIER PACKING MATERIAL TOYO SEIKAN KAISHA, LTD. (JP) 2010-01-21 US disclosed
CN-1972920-A Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms WYETH CORP (US) 2007-05-30 CN disclosed
CN-1897946-A 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms WYETH CORP (US) 2007-01-17 CN disclosed
CN-1898222-A Substituted aryl cycloalkanol derivatives and methods of their use WYETH CORP (US) 2007-01-17 CN disclosed
CN-1897950-A Fused aryl and heteroaryl derivatives and methods of use thereof WYETH CORP (US) 2007-01-17 CN disclosed
WO-2005049631-A1 SYNTHETIC MOLECULES HAVING IMMUNE ACTIVITY THE MALAGHAN INSTITUTE OF MEDICAL RESEARCH (NZ) 2005-06-02 WO disclosed
EP-0371995-B1 PROCESS FOR PRODUCING PHENYLHYDROQUINONES EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1993-01-20 EP disclosed
JP-H03275649-A CYCLOALKANE-1,2-DIOL ESTERS IDEMITSU KOSAN CO LTD 1991-12-06 JP disclosed
EP-0371995-A1 PROCESS FOR PRODUCING PHENYLHYDROQUINONES. EASTMAN KODAK CO (US) 1990-06-13 EP disclosed
US-4847429-A ALKYLATION, ACID CATALYSTS, DEHYDROGENATION EASTMAN KODAK COMPANY (US) 1989-07-11 US disclosed
WO-1989000987-A1 PROCESS FOR PRODUCING PHENYLHYDROQUINONES EASTMAN KODAK COMPANY (US) 1989-02-09 WO disclosed